We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.9B
AUM Growth
+$528M
Cap. Flow
+$375M
Cap. Flow %
1.25%
Top 10 Hldgs %
21.6%
Holding
3,654
New
245
Increased
1,618
Reduced
1,517
Closed
194

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Financials 5.04%
3 Consumer Discretionary 4.21%
4 Healthcare 2.85%
5 Communication Services 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXSQ icon
3401
Oxford Square Capital
OXSQ
$166M
$32K ﹤0.01%
13,156
+1,981
+18% +$5.46K
SGMA
3402
DELISTED
Sigmatron International
SGMA
$31K ﹤0.01%
17,500
+5,000
+40% +$13K
DOUG icon
3403
Douglas Elliman
DOUG
$184M
$30K ﹤0.01%
18,147
+465
+3% +$894
ADIL
3404
Adial Pharmaceuticals
ADIL
$9.43M
$27K ﹤0.01%
+1,080
New +$28.1K
GEVO icon
3405
Gevo
GEVO
$391M
$27K ﹤0.01%
12,758
-1,250
-9% -$2.37K
KOPN icon
3406
Kopin
KOPN
$930M
$27K ﹤0.01%
19,944
LWLG icon
3407
Lightwave Logic
LWLG
$1.23B
$27K ﹤0.01%
12,961
DHF
3408
BNY Mellon High Yield Strategies Fund
DHF
$175M
$26K ﹤0.01%
10,364
-9,111
-47% -$23.8K
HTOO icon
3409
Fusion Fuel Green
HTOO
$17.9M
$26K ﹤0.01%
+1,329
New +$24.1K
ONDS icon
3410
Ondas Inc
ONDS
$5.57B
$26K ﹤0.01%
+10,000
New +$10.4K
SGMO
3411
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$26K ﹤0.01%
25,790
OPTU
3412
Optimum Communications Inc
OPTU
$227M
$24K ﹤0.01%
10,000
-75
-0.7% -$187
IQ icon
3413
iQIYI
IQ
$1.28B
$23K ﹤0.01%
11,344
-16,533
-59% -$39.2K
WTI icon
3414
W&T Offshore
WTI
$555M
$23K ﹤0.01%
+14,027
New +$28K
CUE icon
3415
Cue Biopharma
CUE
$128M
$22K ﹤0.01%
667
SOHO
3416
DELISTED
Sotherly Hotels
SOHO
$22K ﹤0.01%
23,508
-2,200
-9% -$2.45K
AWRE icon
3417
Aware
AWRE
$26M
$21K ﹤0.01%
10,656
-4,926
-32% -$8.4K
REFR icon
3418
Research Frontiers
REFR
$16.8M
$21K ﹤0.01%
12,000
DC.WS
3419
DELISTED
Dakota Gold Corp Warrants
DC.WS
$20K ﹤0.01%
+39,908
New +$25K
TRIB
3420
Trinity Biotech
TRIB
$7.86M
$20K ﹤0.01%
743
GAN
3421
DELISTED
GAN Ltd
GAN
$19K ﹤0.01%
10,240
-273
-3% -$496
RJET
3422
Republic Airways Holdings
RJET
$962M
$19K ﹤0.01%
1,066
PLBY icon
3423
Playboy Inc
PLBY
$149M
$19K ﹤0.01%
13,319
-2,250
-14% -$2.61K
SENS icon
3424
Senseonics Holdings Inc
SENS
$419M
$19K ﹤0.01%
1,859
+545
+41% +$3.89K
NKLA
3425
DELISTED
Nikola Corporation Common Stock
NKLA
$19K ﹤0.01%
+16,340
New +$46.7K

Similar funds

Cambridge Investment Research Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Cambridge Investment Research Advisors held 3,654 positions worth $29.9B, up 1.8% from $29.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambridge Investment Research Advisors's Q4 2024 filing shows 245 new, 1,618 increased, 1,517 reduced and 194 closed positions. Its largest new stake was Innovator Equity Defined Protection ETF - 6mo Apr/Oct: 337,901 shares worth $8.61M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $39.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2024 buy was Innovator Equity Defined Protection ETF - 6mo Apr/Oct: 337,901 shares worth $8.61M.
  • Cambridge Investment Research Advisors added most to JPMorgan Ultra-Short Income ETF in Q4 2024, an estimated $103M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2024 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $39.2M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $17.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 22% of its $29.9B portfolio in Q4 2024.
  • Cambridge Investment Research Advisors opened 245 new positions and closed 194 in Q4 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 1.8% quarter-over-quarter to $29.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.